Health
STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug
Ed Silverman·STAT News·November 10, 2026

Dutch anti-trust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.
Read the full story at STAT News →